Your patient just received devastating news: she has cancer. As treatment options and anxieties swirl, more and more women are now faced with another issue: how will the cancer and its treatment impact their fertility?
Your patient just received devastating news: she has cancer. As treatment options and anxieties swirl, more and more women are now faced with another issue: how will the cancer and its treatment impact their fertility?
Although cancers generally affect older women, women of childbearing age are also impacted. In addition, increasing numbers of women are delaying reproduction and may arrive at this diagnosis thinking fertility was on their horizon. Fortunately, strategies for fertility preservation exist.
So how do you counsel such a patient? Here, Dr Janet McLaren, assistant professor in the division of reproductive endocrinology and infertility at the University of Alabama at Birmingham, offers options for fertility preservation as well as resources for you and your patient.
Fertility Preservation Options in the Face of Cancer
Additional Resources
For Clinicians:
Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630-5.
American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer
“Fertility preservation and reproduction in cancer patients,” The Ethics Committee of the American Society for Reproductive Medicine, American Society for Reproductive Medicine
For Clinicians and Patients:FERTLINE
Fertline provides resources for clinicians and patients and is a good one-stop source to have questions answered.
Fertile Hope
Fertility Hope’s website has a risk calculator as well as fertility resource guide.
American Cancer Society: Information on Preserving Fertility
ACS’s website provides support, information, and answers to frequently asked questions.
The Oncofertility Consortium at Northwestern University
The Consortium has professional resources, news, and information as well as patient support and information.
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More
Metabolomics and proteomics linked to female infertility
January 30th 2024Dive into the latest research in metabolomics and proteomics, revealing potential biomarkers like fibrinogen cleavage peptides and GRAM domain-containing protein 1C, offering new avenues for diagnosis and treatment in addressing the global issue of female infertility.
Read More